Comparing Electromyography of the Diaphragm With Ultrasound in Neonates and Children With Respiratory Support
Launched by LEIDEN UNIVERSITY MEDICAL CENTER · Jul 20, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at two ways to assess how well the diaphragm, the main muscle used for breathing, is working in babies and young children who need help with their breathing in the pediatric intensive care unit (PICU). The study aims to compare two methods: one that measures electrical activity in the diaphragm through the skin (called transcutaneous diaphragm electromyography or dEMG) and another that uses ultrasound (a type of imaging) to see the diaphragm's movements (called diaphragm ultrasound or dUS). By understanding how these two techniques relate to each other, researchers hope to improve the care of young patients with respiratory issues.
To be eligible for this study, babies up to 12 months old needing invasive breathing support may participate, provided they have met certain readiness criteria for coming off that support. Parents will need to give written consent for their child to join the study. The children participating will undergo tests using both dEMG and dUS to help researchers find out how well these methods work together. It's important to note that some children may not be eligible if they have specific medical conditions or are deemed too fragile by their doctor. This trial is currently recruiting participants at the Leiden University Medical Center.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age between 0 - 12 months of age at the moment of inclusion and born ≥ 37 weeks gestational age.
- * Specific patients cohort PICU:
- • pediatric patients with invasive respiratory support comply with the extubation readiness test (ERT) criteria
- • No spontaneous breathing for the duration of the assessment
- • Written parenteral informed consent (IC)
- • A patient can only participate once
- Exclusion Criteria:
- • Unilateral diaphragm paresis diagnosed by ultrasound
- • Congenital malformations not compatible with dEMG
- • Need of cardiac pacing
- • Congenital muscle atrophy disorder
- • Clinical instability requiring frequent interventions by the nursing staff that may interfere with the measurements
- • The attending physician considers the patient to be too vulnerable to participate in the study
About Leiden University Medical Center
Leiden University Medical Center (LUMC) is a prominent academic medical center located in the Netherlands, renowned for its commitment to advancing healthcare through innovative research and high-quality patient care. As a clinical trial sponsor, LUMC focuses on translating scientific discoveries into effective therapies, fostering collaborations between researchers, clinicians, and industry partners. The center is dedicated to conducting rigorous clinical studies across various medical fields, ensuring adherence to ethical standards and regulatory requirements while prioritizing patient safety and outcomes. Through its multidisciplinary approach, LUMC aims to contribute significantly to the understanding and treatment of complex health conditions, driving progress in personalized medicine and improving global health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Leiden, , Netherlands
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported